Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Okey Stephanie

Over the trailing 90 days, Okey Stephanie (Director at Crinetics Pharmaceuticals, Inc.) sold $246K of stock in CRNX, per 4 SEC Form 4 transactions.

Role
Director
Companies
CRNX
Window
Trailing 90 days · 4 transactions · CIK 1742616
Net activity
−$246K ($0 bought · $246K sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
CRNXCrinetics Pharmaceuticals, Inc.4$246K−$246K

Transactions (4)

DateSymbolTypeSharesValueDescription
2026-06-18CRNXBuy9.7K$0Grant, award or other acquisition
2026-06-18CRNXBuy5.9K$0Grant, award or other acquisition
2026-06-17CRNXSell6.3K$224KOpen market or private sale
2026-06-17CRNXSell608$22KOpen market or private sale

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Okey's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free